RxDoctor Payments DataLook up a doctor →

Jeff Bullock, MD

Gastroenterology · San Antonio, TXNPI 1528062288

Payments from drug & device makers

$4,306,694in general payments, 2019–2025

Across 1,316 payments — averaging $3272.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1.2M
  • Eli Lilly$845K
  • Janssen Research & Development, LLC$620K
  • Bristol Myers Squibb$379K
  • Takeda Pharmaceuticals U.S.A., Inc.$338K
  • E.r. Squibb & Sons, L.L.C.$207K
  • plus $669K from 38 others
$32,201in research payments, 2019–2025

Across 9 payments — averaging $3577.91 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$32K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)426$1,249,904
Eli Lilly86$844,635
Janssen Research & Development, LLC234$619,609
Bristol Myers Squibb64$378,723
Takeda Pharmaceuticals U.S.A., Inc.175$338,196
E.r. Squibb & Sons, L.L.C.23$206,612
Ironwood Pharmaceuticals, Inc14$143,941
Shire North American Group Inc26$140,650
Genentech, Inc.16$114,096
GSK16$99,521
Otsuka Pharmaceutical Development & Commercialization, Inc.3$39,357
F. Hoffmann-la Roche AG3$30,846
Astrazeneca UK Limited1$27,591
Boehringer Ingelheim Pharma GmbH & Co.kg8$17,451
Sanofi8$13,014
Boehringer Ingelheim International GmbH1$12,498
Eli Lilly Export S.A. Puerto Rico Branch3$7,325
Pfizer21$7,046
Merck6$6,066
Boehringer Ingelheim3$4,865
Boehringer Ingelheim RCV GmbH & Co KG8$1,573
Johnson & Johnson40$684
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC37$650
Ipsen Biopharmaceuticals, Inc10$200
Ardelyx, Inc.8$178
Madrigal Pharmaceuticals9$174
Aimmune Therapeutics, Inc.9$166
Phathom Pharmaceuticals, Inc.11$159
Lilly USA, LLC8$151
Boston Scientific3$148
Janssen Scientific Affairs, LLC1$130
Nestle Healthcare Nutrition Inc.5$103
Redhill Biopharma Inc.4$79
Gilead3$56
QOL Medical, LLC3$53
Ferring Pharmaceuticals Inc.4$53
Micro-tech Endoscopy USA, Inc.3$39
Celltrion USA Inc.2$38
Evoke Pharma, Inc.2$35
Intercept Pharmaceuticals, Inc.2$26
Daiichi Sankyo Inc.1$25
Braintree Laboratories, Inc.1$14
Olympus America Inc.1$14
Gastrogpo, LLC4$0

How this compares

$4,306,694 in reported general payments places this provider in the 95th percentile of 1,350 gastroenterology providers in Texas.

See all gastroenterology providers in Texas →

Medicare billing

Part B allowed, 2024
$126,699
Medicare patients
490
Services billed
1,590

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other gastroenterology in San Antonio

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →